Literature DB >> 16096000

Mitochondria as functional targets of proteins coded by human tumor viruses.

Donna M D'Agostino1, Paolo Bernardi, Luigi Chieco-Bianchi, Vincenzo Ciminale.   

Abstract

Molecular analyses of tumor virus-host cell interactions have provided key insights into the genes and pathways involved in neoplastic transformation. Recent studies have revealed that the human tumor viruses Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV), and human T-cell leukemia virus type 1 (HTLV-1) express proteins that are targeted to mitochondria. The list of these viral proteins includes BCL-2 homologues (BHRF1 of EBV; KSBCL-2 of KSHV), an inhibitor of apoptosis (IAP) resembling Survivin (KSHV K7), proteins that alter mitochondrial ion permeability and/or membrane potential (HBV HBx, HPV E[wedge]14, HCV p7, and HTLV-1 p13(II)), and K15 of KSHV, a protein with undefined function. Consistent with the central role of mitochondria in energy production, cell death, calcium homeostasis, and redox balance, experimental evidence indicates that these proteins have profound effects on host cell physiology. In particular, the viral BCL-2 homologues BHRF1 and KSBCL-2 inhibit apoptosis triggered by a variety of stimuli. HBx, p7, E1[wedge]4, and p13(II) exert powerful effects on mitochondria either directly due to their channel-forming activity or indirectly through interactions with endogenous channels. Further investigation of these proteins and their interactions with mitochondria will provide important insights into the mechanisms of viral replication and tumorigenesis and could aid in the discovery of new targets for anti-tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16096000     DOI: 10.1016/S0065-230X(05)94003-7

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  24 in total

1.  Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.

Authors:  Ruifang Wang; Yinxing Zhu; Xian Lin; Chenwei Ren; Jiachang Zhao; Fangfang Wang; Xiaochen Gao; Rong Xiao; Lianzhong Zhao; Huanchun Chen; Meilin Jin; Wenjun Ma; Hongbo Zhou
Journal:  Autophagy       Date:  2019-02-20       Impact factor: 16.016

2.  Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  Front Biol (Beijing)       Date:  2014-12

3.  Interactions Between Hepatitis C Virus and Mitochondria: Impact on Pathogenesis and Innate Immunity.

Authors:  Ting Wang; Steven A Weinman
Journal:  Curr Pathobiol Rep       Date:  2013-09

4.  Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.

Authors:  Feifei Li; Wanhua Ren; Yanda Zhao; Zhaoqing Fu; Yongjian Ji; Yuhua Zhu; Chengyong Qin
Journal:  Med Oncol       Date:  2012-04-11       Impact factor: 3.064

5.  Virus inhibition of RIP3-dependent necrosis.

Authors:  Jason W Upton; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

6.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

Review 7.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

8.  The U95 protein of human herpesvirus 6B interacts with human GRIM-19: silencing of U95 expression reduces viral load and abrogates loss of mitochondrial membrane potential.

Authors:  W M Yeo; Yuji Isegawa; Vincent T K Chow
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

9.  Chapter 20 Effects of hepatitis C core protein on mitochondrial electron transport and production of reactive oxygen species.

Authors:  Roosevelt V Campbell; Yuanzheng Yang; Ting Wang; Aparna Rachamallu; Yanchun Li; Stanley J Watowich; Steven A Weinman
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

10.  Immunopathogenesis Versus Protection in Dengue Virus Infections.

Authors:  Alan L Rothman; Carey L Medin; Heather Friberg; Jeffrey R Currier
Journal:  Curr Trop Med Rep       Date:  2014-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.